Thermo Fisher Scientific is acquiring Clario for roughly $8.9 billion, a major move to boost its clinical research services.
The clinical trial ecosystem is entering a phase of consolidation and reinvention driven by the collapse of boundaries between functions, data, and even companies themselves.
The use of Artificial Intelligence (AI) and Machine Learning (ML) in clinical research is rapidly evolving, offering a glimpse into a future where medical innovation is driven by data-driven ...
The way we discover and test new medicines is undergoing a massive transformation for decades the process of bringing a life saving drug to the public was a slow, paper heavy journey that required ...
Traditional trial start-up workflows often follow a sequential path, from feasibility to contracting, then regulatory ...
The Nutrition Care Process (NCP) constitutes a systematic methodology that underpins clinical nutrition practice, guiding dietitians through comprehensive patient assessments, diagnosis, intervention ...
Clinical trials move through four structured phases, from safety testing to long-term effects. Adaptive, basket, and umbrella trials are making cancer research faster and more flexible. Molecular ...
A woman learns about clinical research studies at a CISCRP event. At the heart of all medical treatment, advancement, and the development of cures for devastating diseases is research. Before a new ...
Extracellular vesicles (EVs), including exosomes, microvesicles, apoptotic bodies, and many other EV subtypes, have emerged ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback